People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Biotechnology, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ImmunityBio, Inc. | — | Biotechnology | Growth/Late | $640.1M | $7.8B | 2015 |
| CoRegen, Inc. | — | Biotechnology | Series C | $134.3M | $72.6M | 2022 |
| DemeRx, Inc. | — | Pharmaceuticals | Series A | $28.7M | $9.0M | — |
| H-Cyte, Inc. | — | Other Health Care | Series A | $14.6M | $58.1M | 2018 |
| Nexsis Biosciences LLC | — | Biotechnology | Pre-Seed | $725K | $16.0M | 2021 |
John C. Thomas, Jr. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John C. Thomas, Jr. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Gorlin | 3 | 11 |
| John Thomas, Jr. | 2 | 2 |
| Patrick Soon-Shiong | 1 | 16 |
| John Brennan | 1 | 9 |
| Wesley Clark | 1 | 7 |
| Parker H. Petit | 1 | 5 |
| David Sachs | 1 | 5 |
| Charles Farrahar | 1 | 4 |
| William E. Horne | 1 | 4 |
| Larry Papasan | 1 | 3 |
| Steve J. Gorlin | 1 | 3 |
| Charles E. Koob | 1 | 3 |
| Edward J. Benz, Jr. | 1 | 3 |
| Barry Simon | 1 | 3 |
| Cheryl Cohen | 1 | 3 |
| John Blank | 1 | 2 |
| Randal R. Betz | 1 | 2 |
| Robert G Rosen | 1 | 2 |
| James Andrews | 1 | 2 |
| Jeffrey L. Raney | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.